Dear JSCO Members,
ASCO Breakthrough (#ASCOBT24) will be held in Yokohama, Japan and online this year again, from August 8 to 10, 2024, co-hosted by Japan Society of Clinical Oncology (JSCO) and Japanese Society of Medical Oncology (JSMO).
As innovation in technology accelerate progress in cancer care and improve patient outcomes, ASCO Breakthrough brings together oncology through leaders, med-tec pioneers, novel drug developers, practicing clinicians, and research trailblazers at this can’t-miss meeting in Asia for inspiration, collaboration, and solutions.
And, JSCO/JSMO are jointly operating the incentives, please check the details from :
https://www.jsco.or.jp/news/detail.html?itemid=527&dispmid=767
Abstract submission deadline: APRIL 9, 2024 at 11:59 PM
We are waiting for your participation in 2024 ASCO Breakthrough.
March 12, 2024
Koji Kono, MD, PhD
Chair, International Committee
Japan Society of Clinical Oncology